表紙
市場調査レポート

医薬品開発業務受託機関 (CRO) のラテンアメリカ市場

Latin American Contract Research Organization Market

発行 Frost & Sullivan 商品コード 325795
出版日 ページ情報 英文 234 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=101.55円で換算しております。
Back to Top
医薬品開発業務受託機関 (CRO) のラテンアメリカ市場 Latin American Contract Research Organization Market
出版日: 2015年03月10日 ページ情報: 英文 234 Pages
概要

ラテンアメリカでは、低コストで治験の実施が可能なため、医薬品開発業務受託機関 (CRO) 市場が成長していくでしょう。

当レポートでは、ラテンアメリカ、特にアルゼンチン、ブラジルおよびメキシコにおける医薬品開発業務受託機関 (CRO) 市場の概要と分析を行っており、各国における段階別、治療分野別、地域別の収益状況を提供しています。また、同市場における主な市場発展因子と発展阻害因子、課題、研究開発の動向などについて調査を行っています。

第1章 エグゼクティブサマリー

第2章 市場概要:ラテンアメリカ

  • 市場の見通し
  • CRO市場の状況
  • CRO市場の魅力:段階別
  • ポーターのファイブフォース分析
  • CRO製品の開発と商品化
  • 市場分類:臨床開発段階別

第3章 市場概要:アルゼンチン

  • 主な調査結果
  • 医薬品市場の概要
  • 市場の見通し
  • CRO市場の状況

第4章 治験市場の概要:アルゼンチン

  • 治験市場の概要
  • 治験市場の収益予測
  • 治験のプロファイル
  • 治験のシナリオ
  • 治験の財政援助

第5章 市場発展因子と発展阻害因子:アルゼンチン

  • 市場発展因子と発展阻害因子
  • 市場発展因子
  • 市場発展阻害因子

第6章 CRO市場の予測と動向:アルゼンチン

  • 予測の前提条件
  • 評価
  • 収益予測
  • 市場概況
  • 第1相、第2相
  • 第3相、後期段階
  • データ管理
  • 生物統計学
  • セントラルラボサービス
  • 医療経済およびアウトカム評価 (HEOR)
  • 医薬品安全監視 (ファーマコビジランス)
  • 市販後調査 (PMS)
  • 市場分類:臨床開発段階別
  • 主な市場動向

第7章 規制環境:アルゼンチン

  • 臨床研究に関する規制の概要
  • 臨床研究の規制プロセス

第8章 競合県境:アルゼンチン

  • 競合分析
  • 市場シェア分析
  • 競合構造
  • 主要企業の競合分析

第9章 市場概要:ブラジル

  • 主な調査結果
  • 医薬品市場の概要
  • 市場の見通し
  • CRO市場の状況

第10章 治験市場の概要:ブラジル

  • 治験市場の概要
  • 治験市場の収益予測
  • 治験のプロファイル
  • 治験のシナリオ
  • 治験の財政援助

第11章 市場発展因子と発展阻害因子:ブラジル

  • 市場発展因子と発展阻害因子
  • 市場発展因子
  • 市場発展阻害因子

第12章 CRO市場の予測と動向:ブラジル

  • 予測の前提条件
  • 評価
  • 収益予測
  • 市場概況
  • 第1相、第2相
  • 第3相、後期段階
  • データ管理
  • 生物統計学
  • セントラルラボサービス
  • 医療経済およびアウトカム評価 (HEOR)
  • 医薬品安全監視 (ファーマコビジランス)
  • 市販後調査 (PMS)
  • 市場分類:臨床開発段階別
  • 主な市場動向

第13章 規制環境:ブラジル

  • 臨床研究に関する規制の概要
  • 臨床研究の規制プロセス

第14章 競合県境:ブラジル

  • 競合分析
  • 市場シェア分析
  • 競合構造
  • 主要企業の競合分析

第15章 市場概要:メキシコ

  • 主な調査結果
  • 医薬品市場の概要
  • 市場の見通し
  • CRO市場の状況

第16章 治験市場の概要:メキシコ

  • 治験市場の概要
  • 治験市場の収益予測
  • 治験のプロファイル
  • 治験のシナリオ
  • 治験の財政援助

第17章 市場発展因子と発展阻害因子:メキシコ

  • 市場発展因子と発展阻害因子
  • 市場発展因子
  • 市場発展阻害因子

第18章 CRO市場の予測と動向:メキシコ

  • 予測の前提条件
  • 評価
  • 収益予測
  • 市場概況
  • 第1相、第2相
  • 第3相、後期段階
  • データ管理
  • 生物統計学
  • セントラルラボサービス
  • 医療経済およびアウトカム評価 (HEOR)
  • 医薬品安全監視 (ファーマコビジランス)
  • 市販後調査 (PMS)
  • 市場分類:臨床開発段階別
  • 主な市場動向

第19章 規制環境:メキシコ

  • 臨床研究に関する規制の概要
  • 臨床研究の規制プロセス

第20章 競合県境:メキシコ

  • 競合分析
  • 市場シェア分析
  • 競合構造
  • 主要企業の競合分析

第21章 まとめ

第22章 付録

目次
Product Code: P849-01-00-00-00

Lower Cost of Conducting Clinical Trials will Drive Growth

This research service presents an overview and analysis of the Latin American Contract Research Organization (CRO) market with a focus on Argentina, Brazil, and Mexico. It provides country revenue by phase, therapeutic type, and region. The study discusses key challenges and emerging market trends, while providing detailed information on support services such as central laboratory services. It also outlines market drivers and restraints, market engineering measurements, and research and development trends. The study covers the CRO industry's complete life cycle from phase I trials to post-marketing surveillance, and also highlights emerging trends and their importance in current and future market scenarios.

Key Questions this Study will Answer

  • How will contract research outsourcing help in drug development by saving time and cost for manufacturers?
  • What is the impact of the market growth in different regions?
  • Who are the predominant market participants in the CRO market and what is their market share contribution?
  • What are the key market trends observed towards expansion of contract research organizations in drug development across key therapeutic areas?
  • Are the products/services offered today meeting customer needs or is additional development needed?
  • What are the key market segments to look out for and what are the key trends followed in the market?

Table of Contents

1. EXECUTIVE SUMMARY-LATIN AMERICA

Executive Summary-Latin America

  • 1. Key Findings-LATAM
  • 2. Key Findings-LATAM (continued)
  • 3. Key Findings-LATAM (continued)
  • 4. Key Findings-LATAM (continued)
  • 5. Key Findings-LATAM (continued)
  • 6. Key Findings-LATAM (continued)
  • 7. Market Size Estimation Methodology
  • 8. Scope and Segmentation
  • 9. Key Questions this Study will Answer
  • 10. Measurements-LATAM
  • 11. CEO's Perspective
  • 12. Key Companies to Watch
  • 13. 3 Big Predictions

2. MARKET OVERVIEW-LATIN AMERICA

Market Overview-Latin America

  • 1. Market Perspective-LATAM
  • 2. CRO Market Landscape-LATAM
  • 3. CRO Market Attractiveness by Phase-LATAM
  • 4. Porter's Five Forces Analysis for the LATAM CRO Market
  • 5. CRO Product Development & Commercialization
  • 6. Market Segmentation-By Stages of Clinical Development

3. MARKET OVERVIEW-ARGENTINA

Market Overview-Argentina

  • 1. Key Findings-Argentina
  • 2. Pharmaceutical Market Overview-Argentina
  • 3. Pharmaceutical Market Overview-Argentina (continued)
  • 4. Pharmaceutical Market Overview-Argentina (continued)
  • 5. Pharmaceutical Market Overview-Argentina (continued)
  • 6. Market Perspective-Argentina
  • 7. CRO Market Landscape-Argentina

4. CLINICAL TRIALS MARKET OVERVIEW-ARGENTINA

Clinical Trials Market Overview-Argentina

  • 1. Clinical Trials Market Overview-Argentina
  • 2. Clinical Trials Market Revenue Forecast-Argentina
  • 3. Clinical Trials Market Revenue Forecast Discussion-Argentina
  • 4. Profiles of Clinical Trials-Argentina
  • 5. Profiles of Clinical Trials-Argentina (continued)
  • 6. Clinical Trials Scenario-Argentina
  • 7. Clinical Trials Scenario-Argentina (continued)
  • 8. Clinical Trials Sponsorship-Argentina

5. DRIVERS AND RESTRAINTS-ARGENTINA

Drivers and Restraints-Argentina

  • 1. Drivers and Restraints-Argentina
  • 2. Drivers Explained-Argentina
  • 3. Drivers Explained-Argentina (continued)
  • 4. Restraints Explained-Argentina
  • 5. Restraints Explained-Argentina (continued)

6. FORECASTS AND TRENDS: CRO MARKET-ARGENTINA

Forecasts and Trends: CRO Market-Argentina

  • 1. Forecast Assumptions
  • 2. Measurements-Argentina
  • 3. Argentina CRO Market-Revenue Forecast
  • 4. Argentina CRO Market-Revenue Forecast Discussion
  • 5. CRO Market Snapshot-Argentina
  • 6. Argentina CRO Market-Phase I & Phase II
  • 7. Argentina CRO Market-Phase III & Late Phase
  • 8. Argentina CRO Market-Data Management
  • 9. Argentina CRO Market-Data Management (continued)
  • 10. Argentina CRO Market-Biostatistics
  • 11. Argentina CRO Market-Biostatistics(continued)
  • 12. Argentina CRO Market-Central Laboratory Services
  • 13. Argentina CRO Market-Central Laboratory Services (continued)
  • 14. Argentina CRO Market-Health Economics and Outcomes Research (HEOR)
  • 15. Argentina CRO Market-Health Economics and Outcomes Research (continued)
  • 16. Argentina CRO Market-Pharmacovigilance
  • 17. Argentina CRO Market-Pharmacovigilance (continued)
  • 18. Argentina CRO Market-Postmarketing Surveillance
  • 19. Argentina CRO Market-Postmarketing Surveillance (continued)
  • 20. Argentina CRO Market Segmentation-By Stages of Clinical Development
  • 21. Key Market Trends-Argentina

7. REGULATORY ENVIRONMENT-ARGENTINA

Regulatory Environment-Argentina

  • 1. Clinical Research Regulatory Overview-Argentina
  • 2. Clinical Research Regulatory Process-Argentina
  • 3. Clinical Research Regulatory Process-Argentina (continued)
  • 4. Clinical Research Regulatory Process-Argentina (continued)

8. COMPETITIVE ENVIRONMENT-ARGENTINA

Competitive Environment-Argentina

  • 1. Competitive Analysis-Argentina
  • 2. Market Share Analysis-Argentina
  • 3. Competitive Structure-Argentina
  • 4. Competitive Analysis-Selected Key Market Participants
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)
  • 7. Competitive Analysis-Selected Key Market Participants (continued)
  • 8. Competitive Analysis-Selected Key Market Participants (continued)
  • 9. Competitive Analysis-Selected Key Market Participants (continued)

9. MARKET OVERVIEW-BRAZIL

Market Overview-Brazil

  • 1. Key Findings-Brazil
  • 2. Pharmaceutical Market Overview-Brazil
  • 3. Pharmaceutical Market Overview-Brazil (continued)
  • 4. Pharmaceutical Market Overview-Brazil (continued)
  • 5. Pharmaceutical Market Overview-Brazil (continued)
  • 6. Pharmaceutical Market Overview-Brazil (continued)
  • 7. Pharmaceutical Market Overview-Brazil (continued)
  • 8. Market Perspective-Brazil
  • 9. CRO Market Landscape-Brazil

10. CLINICAL TRIALS MARKET OVERVIEW-BRAZIL

Clinical Trials Market Overview-Brazil

  • 1. Clinical Trials Market Overview-Brazil
  • 2. Clinical Trials Market Revenue Forecast-Brazil
  • 3. Clinical Trials Market Revenue Forecast Discussion-Brazil
  • 4. Profiles of Clinical Trials-Brazil
  • 5. Profiles of Clinical Trials-Brazil (continued)
  • 6. Clinical Trials Scenario-Brazil
  • 7. Clinical Trials Scenario-Brazil (continued)
  • 8. Clinical Trials Sponsorship-Brazil

11. DRIVERS AND RESTRAINTS-BRAZIL

Drivers and Restraints-Brazil

  • 1. Drivers and Restraints-Brazil
  • 2. Drivers Explained-Brazil
  • 3. Drivers Explained-Brazil (continued)
  • 4. Drivers Explained-Brazil (continued)
  • 5. Restraints Explained-Brazil
  • 6. Restraints Explained-Brazil (continued)

12. FORECASTS AND TRENDS: CRO MARKET-BRAZIL

Forecasts and Trends: CRO Market-Brazil

  • 1. Forecast Assumptions
  • 2. Measurements-Brazil
  • 3. Brazil CRO Market-Revenue Forecast
  • 4. Brazil CRO Market-Revenue Forecast Discussion
  • 5. CRO Market Snapshot-Brazil
  • 6. Brazil CRO Market-Phase I & Phase II
  • 7. Brazil CRO Market-Phase III & Late Phase
  • 8. Brazil CRO Market-Data Management
  • 9. Brazil CRO Market-Data Management (continued)
  • 10. Brazil CRO Market-Biostatistics
  • 11. Brazil CRO Market-Biostatistics (continued)
  • 12. Brazil CRO Market-Central Laboratory Services
  • 13. Brazil CRO Market-Central Laboratory Services (continued)
  • 14. Brazil CRO Market-Health Economics and Outcomes Research (HEOR)
  • 15. Brazil CRO Market-Health Economics and Outcomes Research (continued)
  • 16. Brazil CRO Market-Pharmacovigilance
  • 17. Brazil CRO Market-Pharmacovigilance (continued)
  • 18. Brazil CRO Market-Postmarketing Surveillance
  • 19. Brazil CRO Market-Postmarketing Surveillance (continued)
  • 20. Brazil CRO Market Segmentation-By Stages of Clinical Development
  • 21. Key Market Trends-Brazil

13. REGULATORY ENVIRONMENT-BRAZIL

Regulatory Environment-Brazil

  • 1. Clinical Research Regulatory Overview-Brazil
  • 2. Clinical Research Regulatory Overview-Brazil (continued)
  • 3. Clinical Research Regulatory Overview-Brazil (continued)
  • 4. Clinical Research Regulatory Process-Brazil

14. COMPETITIVE ENVIRONMENT-BRAZIL

Competitive Environment-Brazil

  • 1. Competitive Analysis-Brazil
  • 2. Market Share Analysis-Brazil
  • 3. Competitive Structure-Brazil
  • 4. Competitive Analysis-Selected Key Market Participants
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)
  • 7. Competitive Analysis-Selected Key Market Participants (continued)
  • 8. Competitive Analysis-Selected Key Market Participants (continued)
  • 9. Competitive Analysis-Selected Key Market Participants (continued)
  • 10. Competitive Analysis-Selected Key Market Participants (continued)

15. MARKET OVERVIEW-MEXICO

Market Overview-Mexico

  • 1. Key Findings-Mexico
  • 2. Pharmaceutical Market Overview-Mexico
  • 3. Pharmaceutical Market Overview-Mexico (continued)
  • 4. Pharmaceutical Market Overview-Mexico (continued)
  • 5. Pharmaceutical Market Overview-Mexico (continued)
  • 6. Pharmaceutical Market Overview-Mexico (continued)
  • 7. Market Perspective-Mexico
  • 8. CRO Market Landscape-Mexico

16. CLINICAL TRIALS MARKET OVERVIEW-MEXICO

Clinical Trials Market Overview-Mexico

  • 1. Clinical Trials Market Overview-Mexico
  • 2. Clinical Trials Market Revenue Forecast-Mexico
  • 3. Clinical Trials Market Revenue Forecast Discussion-Mexico
  • 4. Profiles of Clinical Trials-Mexico
  • 5. Profiles of Clinical Trials-Mexico (continued)
  • 6. Clinical Trials Scenario-Mexico
  • 7. Clinical Trials Scenario-Mexico (continued)
  • 8. Clinical Trials Sponsorship-Mexico

17. DRIVERS AND RESTRAINTS-MEXICO

Drivers and Restraints-Mexico

  • 1. Drivers and Restraints-Mexico
  • 2. Drivers Explained-Mexico
  • 3. Drivers Explained-Mexico (continued)
  • 4. Restraints Explained-Mexico
  • 5. Restraints Explained-Mexico (continued)

18. FORECASTS AND TRENDS: CRO MARKET-MEXICO

Forecasts and Trends: CRO Market-Mexico

  • 1. Forecast Assumptions
  • 2. Measurements-Mexico
  • 3. Mexico CRO Market-Revenue Forecast
  • 4. Mexico CRO Market-Revenue Forecast Discussion
  • 5. CRO Market Snapshot-Mexico
  • 6. Mexico CRO Market-Phase I & Phase II
  • 7. Mexico CRO Market-Phase IIII & Late Phase
  • 8. Mexico CRO Market-Data Management
  • 9. Mexico CRO Market-Data Management (continued)
  • 10. Mexico CRO Market-Biostatistics
  • 11. Mexico CRO Market-Biostatistics (continued)
  • 12. Mexico CRO Market-Central Laboratory Services
  • 13. Mexico CRO Market-Central Laboratory Services (continued)
  • 14. Mexico CRO Market-Health Economics and Outcomes Research (HEOR)
  • 15. Mexico CRO Market-Health Economics and Outcomes Research (continued)
  • 16. Mexico CRO Market-Pharmacovigilance
  • 17. Mexico CRO Market-Pharmacovigilance (continued)
  • 18. Mexico CRO Market-Postmarketing Surveillance
  • 19. Mexico CRO Market-Postmarketing Surveillance (continued)
  • 20. Mexico CRO Market Segmentation-By Stages of Clinical Development
  • 21. Key Market Trends-Mexico

19. REGULATORY ENVIRONMENT-MEXICO

Regulatory Environment-Mexico

  • 1. Clinical Research Regulatory Overview-Mexico
  • 2. Clinical Research Regulatory Overview-Mexico (continued)
  • 3. Clinical Research Regulatory Overview-Mexico (continued)
  • 4. Clinical Research Regulatory Process-Mexico

20. COMPETITIVE ENVIRONMENT-MEXICO

Competitive Environment-Mexico

  • 1. Competitive Analysis-Mexico
  • 2. Market Share Analysis-Mexico
  • 3. Competitive Structure-Mexico
  • 4. Competitive Analysis-Selected Key Market Participants
  • 5. Competitive Analysis-Selected Key Market Participants (continued)
  • 6. Competitive Analysis-Selected Key Market Participants (continued)
  • 7. Competitive Analysis-Selected Key Market Participants (continued)
  • 8. Competitive Analysis-Selected Key Market Participants (continued)
  • 9. Competitive Analysis-Selected Key Market Participants (continued)
  • 10. Competitive Analysis-Selected Key Market Participants (continued)

21. THE LAST WORD

The Last Word

  • 1. 3 Big Predictions
  • 2. The Last Word-Discussion
  • 3. Legal Disclaimer

22. APPENDIX

Appendix

  • 1. List of Exhibits
  • 2. List of Exhibits (continued)
  • 3. List of Exhibits (continued)
  • 4. List of Exhibits (continued)
  • 5. List of Exhibits (continued)
  • 6. List of Exhibits (continued)
  • 7. List of Exhibits (continued)
  • 8. List of Exhibits (continued)
  • 9. List of Exhibits (continued)
  • 10. Methodology
  • 11. Learn More-Next Steps

List of Exhibits

  • Total CRO Market: Market Snapshot, LATAM, 2013
  • Total CRO Market: Market Snapshot by Geography, LATAM, 2013-2019
  • Total CRO Market: Market Engineering Measurements, LATAM, 2013
  • Total CRO Market: Clinical Research Outsourcing Landscape, LATAM, 2013
  • Total CRO Market: Market Attractiveness by Phase, LATAM, 2013
  • Total CRO Market: Stages of Clinical Development, Global, 2014
  • Total CRO Market: Market Segmentation by Stages of Clinical Development, LATAM, 2013
  • Pharmaceutical Market: Revenue Forecast, Argentina, 2010-2019
  • Pharmaceutical Market: Market Share of Top Pharma by Retail Sales, Argentina, 2013
  • Pharmaceutical Market: Top 10 Pharma Companies by Retail Sales, Argentina, 2013
  • CRO Market: Clinical Research Outsourcing Landscape, Argentina, 2013
  • Clinical Trials Market: Revenue Forecast, Argentina, 2013-2019
  • Clinical Trials Market: No. of Clinical Trials by Therapeutic Area, Argentina, 2013
  • Clinical Trials Market: No. of New Clinical Trials by Drug Type, Argentina, 2013
  • Clinical Trials Market: No. of Open and New Trials, Argentina, 2009-2013
  • Clinical Trials Market: No. of New Clinical Trials by Start Year, Argentina, 2009-2013
  • Clinical Trials Market: Revenue Forecast, MNC Pharmas Vs Local Pharmas, Argentina, 2013-2019
  • Clinical Trials Market: Revenue Forecast, Global Trials Vs Local Trials, Argentina, 2013-2019
  • Clinical Trials Market: Key Market Drivers and Restraints, Argentina, 2014-2019
  • CRO Market: Market Engineering Measurements, Argentina, 2013
  • CRO Market: Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Market Snapshot, Argentina, 2013-2019
  • CRO Market: Phase I, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Phase II, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Phase III, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Late Phase, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Data Management, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Biostatistics, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Central Laboratory Services, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: HEOR, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Pharmacovigilance, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Postmarketing Surveillance, Revenue Forecast, Argentina, 2013-2019
  • CRO Market: Revenue Breakdown by Stages of Clinical Development, Argentina, 2013
  • CRO Market: Clinical Research Regulatory Process, Argentina, 2013
  • CRO Market: Percent Revenue Breakdown, Argentina, 2013
  • Clinical Trials Market: Competitive Analysis-Quintiles, Argentina, 2013
  • Clinical Trials Market: Competitive Analysis-PPD, Argentina, 2013
  • Clinical Trials Market: Competitive Analysis-Parexel, Argentina, 2013
  • Clinical Trials Market: Competitive Analysis-Covance, Argentina, 2013
  • Clinical Trials Market: Competitive Analysis-ICON, Argentina, 2013
  • Clinical Trials Market: Competitive Analysis-Main Local Competitors, Argentina, 2013
  • Pharmaceutical Market: Revenue Forecast, Brazil, 2010-2019
  • Pharmaceutical Market: Top 20 Pharma Companies by Retail Sales, Brazil, 2013
  • CRO Market: Clinical Research Outsourcing Landscape, Brazil, 2013
  • Clinical Trials Market: Revenue Forecast, Brazil, 2013-2019
  • Clinical Trials Market: No. of Clinical Trials by Therapeutic Area, Brazil, 2013
  • Clinical Trials Market: No. of New Clinical Trials by Drug Type, Brazil, 2013
  • Clinical Trials Market: No. of Open and New Trials, Brazil, 2009-2013
  • Clinical Trials Market: No. of New Clinical Trials by Start Year, Brazil, 2009-2013
  • Clinical Trials Market: Revenue Forecast, MNC Pharmas Vs Local Pharmas, Brazil, 2013-2019
  • Clinical Trials Market: Revenue Forecast, Global Trials Vs Local Trials, Brazil, 2013-2019
  • CRO Market: Key Market Drivers and Restraints, Brazil, 2014-2019
  • CRO Market: Market Engineering Measurements, Brazil, 2013
  • CRO Market: Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Market Snapshot, Brazil, 2013-2019
  • CRO Market: Phase I, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Phase II, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Phase III, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Late Phase, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Data Management, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Biostatistics, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Central Laboratory Services, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: HEOR, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Pharmacovigilance, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Postmarketing Surveillance, Revenue Forecast, Brazil, 2013-2019
  • CRO Market: Revenue Breakdown by Stages of Clinical Development, Brazil, 2013
  • CRO Market: Clinical Research Regulatory Process, Brazil, 2013
  • CRO Market: Percent Revenue Breakdown, Brazil, 2013
  • Clinical Trials Market: Competitive Analysis-Quintiles, Brazil, 2013
  • Clinical Trials Market: Competitive Analysis-PPD, Brazil, 2013
  • Clinical Trials Market: Competitive Analysis-PRA/RPS, Brazil, 2013
  • Clinical Trials Market: Competitive Analysis-Parexel, Brazil, 2013
  • Clinical Trials Market: Competitive Analysis-Covance, Brazil, 2013
  • Clinical Trials Market: Competitive Analysis-Main Local Competitors, Brazil, 2013
  • Pharmaceutical Market: Revenue Forecast, Mexico, 2010-2019
  • Pharmaceutical Market: Evolution of Pharmaceutical Regulation, Mexico, 2001-2014
  • Pharmaceutical Market: Top 20 Pharma Companies by Retail Sales, Mexico, 2013
  • CRO Market: Clinical Research Outsourcing Landscape, Mexico, 2013
  • Clinical Trials Market: Revenue Forecast, Mexico, 2013-2019
  • Clinical Trials Market: No. of Clinical Trials by Therapeutic Area, Mexico, 2013
  • Clinical Trials Market: No. of New Clinical Trials by Drug Type, Mexico, 2013
  • Clinical Trials Market: No. of Open and New Trials, Mexico, 2009-2013
  • Clinical Trials Market: No. of New Clinical Trials by Start Year, Mexico, 2009-2013
  • Clinical Trials Market: Revenue Forecast, MNC Pharmas Vs Local Pharmas, Mexico, 2013-2019
  • Clinical Trials Market: Revenue Forecast, Global trials Vs Local trials, Mexico, 2013-2019
  • Clinical Trials Market: Key Market Drivers and Restraints, Mexico, 2014-2019
  • CRO Market: Market Engineering Measurements, Mexico, 2013
  • CRO Market: Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Market Snapshot, Mexico, 2013-2019
  • CRO Market: Phase I, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Phase II, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Phase III, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Late Phase, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Data Management, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Biostatistics, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Central Laboratory Services, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: HEOR, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Pharmacovigilance, Revenue Forecast, Mexico 2013-2019
  • CRO Market: Postmarketing Surveillance, Revenue Forecast, Mexico, 2013-2019
  • CRO Market: Revenue Breakdown by Stages of Clinical Development, Mexico, 2013
  • CRO Market: Clinical Research Regulatory Overview-Regulatory Authorities, Mexico, 2013
  • CRO Market: Clinical Research Regulatory Process, Mexico, 2013
  • CRO Market: Percent Revenue Breakdown, Mexico, 2013
  • Clinical Trials Market: Competitive Analysis-Quintiles, Mexico, 2013
  • Clinical Trials Market: Competitive Analysis-PPD, Mexico, 2013
  • Clinical Trials Market: Competitive Analysis-Parexel, Mexico, 2013
  • Clinical Trials Market: Competitive Analysis-Covance, Mexico, 2013
  • Clinical Trials Market: Competitive Analysis-ICON, Mexico, 2013
  • Clinical Trials Market: Competitive Analysis-Main Local Competitors, Mexico, 2013
Back to Top